MistVapor USA
Letter data
- Company
- MistVapor USA
- Recipient
- MistVapor USA | United States | service@mistvapor.com
- Issue date
- 2020-11-02
- Posted date
- Not available
- FDA office
- Office of Compliance and Enforcement
- Subject
- Not available
- Product
- Tobacco
- CMS ID
- 610014
- Reference number
- RW2001407
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
MistVapor USA
MARCS-CMS 610014 —
November 02, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Reference #:
RW2001407
Product:
Tobacco
Recipient:
MistVapor USA
United States
service@mistvapor.com
Issuing Office:
Office of Compliance and Enforcement
United States
Dear Sir or Madam:
The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions in response to our Warning Letter dated August 14, 2020. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://mistvapor.com.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
Content current as of:
12/01/2020
Regulated Product(s)
Tobacco